News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
16,518 Results
Type
Article (968)
Company Profile (9)
Press Release (15541)
Section
Business (3956)
Career Advice (61)
Deals (621)
Drug Development (1783)
Employer Resources (1)
FDA (492)
Job Trends (556)
News (6952)
Policy (591)
Tag
2026 BioCapital Elite (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (123)
Allergies (3)
Alliances (1375)
Alzheimer's disease (93)
Antibody-drug conjugate (ADC) (4)
Approvals (505)
Artificial intelligence (16)
Bankruptcy (4)
Best Places to Work (555)
BIOSECURE Act (1)
Biotechnology (4)
Bladder cancer (3)
Brain cancer (3)
Breast cancer (14)
Cancer (122)
Cardiovascular disease (10)
Career advice (56)
CAR-T (3)
Cell therapy (11)
Clinical research (1535)
Collaboration (42)
Compensation (5)
COVID-19 (41)
C-suite (3)
Cystic fibrosis (3)
Data (120)
Depression (1)
Diabetes (4)
Diagnostics (311)
Digital health (2)
Drug discovery (3)
Drug pricing (1)
Earnings (1426)
Editorial (1)
Employer resources (1)
Events (2369)
Executive appointments (6)
FDA (559)
Featured Employer (3)
Funding (17)
Gene editing (1)
Gene therapy (10)
GLP-1 (19)
Government (120)
Guidances (4)
Healthcare (493)
IgA nephropathy (3)
Immunology and inflammation (5)
Indications (3)
Infectious disease (43)
Inflammatory bowel disease (7)
Influenza (1)
Intellectual property (1)
Interviews (13)
IPO (226)
IRA (1)
Job creations (67)
Job search strategy (51)
Kidney cancer (3)
Layoffs (8)
Leadership (1)
Legal (74)
Liver cancer (1)
Lung cancer (42)
Lymphoma (7)
Management (1)
Manufacturing (12)
MASH (4)
Medical device (383)
Medtech (384)
Mergers & acquisitions (425)
Metabolic disorders (11)
Multiple sclerosis (1)
Neurodegenerative disease (2)
Neuroscience (109)
NextGen: Class of 2025 (174)
Non-profit (210)
Northern California (50)
Now hiring (1)
Obesity (3)
Opinion (4)
Ovarian cancer (4)
Pancreatic cancer (2)
Parkinson's disease (6)
Partnered (1)
Patents (3)
Patient recruitment (3)
Peanut (2)
People (881)
Pharmaceutical (2)
Phase I (390)
Phase II (637)
Phase III (628)
Pipeline (38)
Podcasts (4)
Policy (2)
Postmarket research (32)
Preclinical (150)
Press Release (4)
Prostate cancer (12)
Radiopharmaceuticals (59)
Rare diseases (8)
Real estate (157)
Regulatory (477)
Reports (3)
Research institute (118)
Resumes & cover letters (4)
Schizophrenia (4)
Series A (6)
Series B (2)
Southern California (90)
Sponsored (1)
Startups (76)
Tariffs (1)
The Weekly (4)
United States (601)
Vaccines (9)
Venture capitalists (1)
Weight loss (1)
Worklife (1)
Date
Today (4)
Last 7 days (27)
Last 30 days (110)
Last 365 days (1179)
2025 (326)
2024 (1143)
2023 (1135)
2022 (1589)
2021 (1629)
2020 (1154)
2019 (1277)
2018 (941)
2017 (770)
2016 (750)
2015 (824)
2014 (619)
2013 (517)
2012 (567)
2011 (592)
2010 (571)
Location
Africa (33)
Alaska (1)
Arizona (3)
Asia (908)
Australia (242)
California (159)
Canada (51)
China (7)
Colorado (7)
Connecticut (11)
Delaware (7)
Europe (2643)
Florida (23)
Georgia (9)
Idaho (2)
Illinois (64)
Indiana (17)
Iowa (2)
Japan (13)
Maine (1)
Maryland (33)
Massachusetts (75)
Michigan (3)
Minnesota (5)
Missouri (2)
Nevada (2)
New Hampshire (18)
New Jersey (58)
New Mexico (1)
New York (28)
North Carolina (21)
Northern California (50)
Ohio (2)
Oregon (1)
Pennsylvania (30)
Rhode Island (6)
South America (48)
South Dakota (1)
Southern California (90)
Tennessee (2)
Texas (23)
Utah (1)
Virginia (2)
Washington D.C. (2)
Washington State (13)
Wisconsin (2)
16,518 Results for "ocean tomo".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
GENFIT Announces Final Terms for Dual Proposal to the 2025 OCEANEs Holders
February 10, 2025
·
9 min read
Press Releases
GENFIT Announces Completion of Non-dilutive Royalty Financing Agreement with HCRx and Results of Repurchase Offer to 2025 OCEANEs holders
March 21, 2025
·
9 min read
Press Releases
Ocean Biomedical Announces Grant on Patent Right for Bispecific Antibodies Targeting CHI3L1 and PD1 for Enhanced Tumor Cell Cytotoxicity in China
March 28, 2025
·
4 min read
Biotech Beach
Endonovo Retains Ocean Tomo, a Part of J.S. Held, to Provide Fairness Opinion Analysis for Medical Device Spin-Off
Endonovo Therapeutics, Inc. announced the retention of Ocean Tomo, a part of J.S. Held, to conduct a fairness opinion analysis in connection with the proposed spin-off of Endonovo’s medical device assets to a newly formed Delaware company, SofPulse, Inc.
January 31, 2023
·
4 min read
Press Releases
Ocean Biomedical Advances Malaria Vaccine Research with New NIH Funding and Expedited Development Pathway
January 29, 2025
·
8 min read
Press Releases
Ocean Biomedical Announces Breakthrough Findings in EGFR-Mutant Lung Cancer and Plans for FDA Alignment on Next-Stage Development
February 10, 2025
·
8 min read
Press Releases
Longboard Pharmaceuticals Initiates Phase 3 DEEp OCEAN Study Evaluating Bexicaserin in Developmental and Epileptic Encephalopathies (DEEs)
November 12, 2024
·
7 min read
Press Releases
Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
November 25, 2024
·
5 min read
Pharm Country
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Potential Capability to Protect Against Infection and Treat Severe Disease
Ocean Biomedical (NASDAQ: OCEA ) announced today that Scientific Co-founder Dr. Jonathan Kurtis, MD, PhD, has been granted a new patent for his malaria therapeutic antibody discoveries, targeted to both prevent malaria infection and treat severe malaria.
May 16, 2024
·
7 min read
BioMidwest
Accuray Announces Approval of the Tomo® C Radiation Treatment Delivery System by China’s National Medical Products Administration
Accuray Incorporated announced that the registration dossier for the CNNC-Accuray joint venture Tomo® C radiation therapy system for the Type B market has been approved by the Chinese National Medical Products Administration.
October 3, 2023
·
4 min read
1 of 1,652
Next
